Naoto T. Ueno/LinkedIn
Aug 1, 2024, 06:24
TOWARDS Study: Xenograft Engraftment Predicts Poor Survival in TNBC
Naoto T. Ueno, Director at University of Hawaii Cancer Center, shared a post on X, about a recent paper published in JCO Precision Oncology:
Authors: Christos Vaklavas, Cindy B. Matsen, Zhengtao Chu, Kenneth M. Boucher, Sandra D. Scherer, Satya Pathi, Anna Beck, Kirstyn E. Brownson, Saundra S. Buys, Namita Chittoria, Elyse D’Astous, H. Evin Gulbahce, N. Lynn Henry, Stephen Kimani, Jane Porretta, Regina Rosenthal, John Ward, Mei Wei, Bryan E. Welm, Alana L. Welm.
”A fascinating result is that engraftment to develop PDX predicts the response to systemic treatment in patients with triple-negative breast cancer. This is an article by a great cancer biologist, Alana Welm.”
Source: Naoto T. Ueno/X
Alana Welm
Anna Beck
Breast Cancer
Bryan E. Welm
cancer
cancer treatment
Christos Vaklavas
Cindy B. Matsen
Elyse D'Astous
H. Evin Gulbahce
Jane Porretta
JCO Precision Oncology
John Ward
Kenneth M. Boucher
Kirstyn E. Brownson
Mei Wei
N. Lynn Henry
Namita Chittoria
Naoto T Ueno
OncoDaily
Oncology
Regina Rosenthal
Sandra D. Scherer
Satya Pathi
Saundra S. Buys
Stephen Kimani
University of Hawaii Cancer Center
Zhengtao Chu
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19